Deerfield Management Company, L.P. (Series C) Agios Pharmaceuticals, Inc. Transaction History

Deerfield Management Company, L.P. (Series C)

$5.38 Billion
Q3 2024

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$21.32 - $34.81 $376,468 - $614,674	17,658 New	17,658 $516,000
Q4 2018 Feb 14, 2019	SELL	$42.73 - $76.53 $14.9 Million - $26.6 Million	-348,200 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$71.67 - $91.95 $129,006 - $165,510	-1,800 Reduced 0.51%	348,200 $26.9 Million
Q2 2018 Aug 14, 2018	SELL	$73.22 - $99.55 $1.17 Million - $1.59 Million	-16,000 Reduced 4.37%	350,000 $29.5 Million
Q1 2018 May 15, 2018	BUY	$59.83 - $86.53 $6.16 Million - $8.91 Million	103,016 Added 39.17%	366,000 $29.9 Million
Q4 2017 Feb 14, 2018	BUY	$52.12 - $72.33 $2.87 Million - $3.98 Million	54,984 Added 26.43%	262,984 $15 Million
Q3 2017 Nov 13, 2017	BUY	$54.89 - $67.12 $11.4 Million - $14 Million	208,000	208,000 $13.9 Million

Others Institutions Holding AGIO

# of Institutions

232

Shares Held

58.1M

Call Options Held

403K

Put Options Held

469K

Farallon Capital Management LLC San Francisco, CA

5.66M
Shares

$195 Million
1.26% of portfolio
Vanguard Group Inc Valley Forge, PA

5.55M
Shares

$191 Million
0.0% of portfolio
Black Rock Inc. New York, NY

4.86M
Shares

$167 Million
0.0% of portfolio
Bellevue Group Ag Kuesnacht, V8

3.74M
Shares

$129 Million
2.8% of portfolio
Price T Rowe Associates Inc Baltimore, MD

2.83M
Shares

$97.5 Million
0.01% of portfolio

View Full List

About AGIOS PHARMACEUTICALS, INC.

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $1.89B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

More about AGIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deerfield Management Company, L.P. (Series C), based on Form 13F filings with the SEC.

News

Stay updated on Deerfield Management Company, L.P. (Series C) with notifications on news.

Account